Jaime Leandro Foundation For Therapeutic Cancer Vaccines
EIN: 853117614 · Chapel Hill, NC · NTEE: G30
About Jaime Leandro Foundation For Therapeutic Cancer Vaccines
Jaime Leandro Foundation For Therapeutic Cancer Vaccines (EIN: 853117614) is a nonprofit organization based in Chapel Hill, NC, classified under NTEE code G30. The organization reported total revenue of $4.8M and total assets of $3.0M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Jaime Leandro Foundation For Therapeutic Cancer Vaccines's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
AI Analysis Pending
AI enrichment for Jaime Leandro Foundation For Therapeutic Cancer Vaccines has not yet been completed. Basic IRS 990 data is shown below. Check back later for a full transparency report including a Mission Score, spending breakdown, executive compensation analysis, and red flags assessment.
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Jaime Leandro Foundation For Therapeutic Cancer Vaccines with a Mission Score of 0 out of 100 (Very Poor). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Filing History
IRS 990 filing history for Jaime Leandro Foundation For Therapeutic Cancer Vaccines showing financial trends over 3 years of public records:
Over 3 years of IRS 990 filings (2021–2023), Jaime Leandro Foundation For Therapeutic Cancer Vaccines's revenue has grown by 641.7%, moving from $336K to $2.5M. Total assets increased by 237.4% over the same period, from $278K to $938K. Total functional expenses rose by 460%, from $416K to $2.3M. In its most recent filing year (2023), Jaime Leandro Foundation For Therapeutic Cancer Vaccines reported a surplus of $159K, with revenue exceeding expenses. The organization holds $795K in liabilities against $938K in assets (debt-to-asset ratio: 84.7%), resulting in net assets of $143K.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. | |
|---|---|---|---|---|---|---|
| 2023 | $2.5M | $2.3M | $938K | $795K | — | — |
| 2022 | $1.3M | $1.3M | $546K | $562K | — | View 990 |
| 2021 | $336K | $416K | $278K | $358K | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $2.5M, expenses of $2.3M, and assets of $938K (revenue +85.2% year-over-year).
- 2022: Revenue of $1.3M, expenses of $1.3M, and assets of $546K (revenue +300.5% year-over-year).
- 2021: Revenue of $336K, expenses of $416K, and assets of $278K.
Data Sources and Methodology
This transparency report for Jaime Leandro Foundation For Therapeutic Cancer Vaccines is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.